This is in agreement with previous studies [2] and supports the hypothesis that tyrosin kinase activation through FLT3-ITD mutations is a sufficient cooperating event to produce APL and therefore, other genomic aberrations such as CNAs are not needed. This evidence concerns the gene FLT3 and acute promyelocytic leukemia.